Remove Financial Market Remove Medicine Remove Portfolio
article thumbnail

2025 Q1 Update: Federal Reserve Rates, Inflation and Financial Markets

Your Richest Life

The cost increase last month affected expenses like car insurance, airfare, medicine and groceries. 2025 may prove to be a bumpy ride, but a strong, well-balanced portfolio is designed to weather storms. The post 2025 Q1 Update: Federal Reserve Rates, Inflation and Financial Markets appeared first on Your Richest Life.

article thumbnail

Fundamental Analysis Of Divis Laboratories – Profitability & More

Trade Brains

Overview: Indian Pharmaceutical Industry When you consume medicine for certain ailments and diseases, you’re recommended by your doctor to consume it for its curing effect. Some notable pharmaceutical companies have made their way to the Nifty Index and we’re going to perform a fundamental analysis of Divis Laboratories. FY 19 0.015 531.02

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fundamental Analysis Of Lupin – Industry Analysis and Financials

Trade Brains

Fundamental Analysis Of Lupin : Medicines are substances that can be used to prevent, treat, or cure disease. Pharmaceutical companies in India have come a long way in supplying medicines, and with more research, they are improving their products. Segment Analysis The company’s revenue was Rs. crore in FY23.

article thumbnail

Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More

Trade Brains

It is the world’s largest supplier of generic medicine, in terms of volume with a 20% market share. According to the Economic Survey 2023, India’s domestic pharmaceutical market was estimated at $41 billion. This portfolio is boosted by the successful launch of gRevlimid. Reddy’s Laboratories Ltd.

article thumbnail

High FII Holding Stocks Under Rs 500 To Add To Your Watchlist

Trade Brains

Net profit has decreased due to an increase in fixed-cost expenses such as employee costs and the purchase of medicines and consumables. Market Cap (Cr.) ₹ 19,963 RoE (%) 11.32% RoCE (%) 14.36% P/E (TTM) 61.4 The company’s net profits were Rs. crore in FY23, up from Rs. crore in FY22, a -20.95% decrease. Price to Book Value 3.99

article thumbnail

Fundamental Analysis Of Tata Chemicals – Financials, Future Plans & More

Trade Brains

Excluding table salt, other chemicals find their end applications in the manufacturing of glass, paper products, medicines & drugs, and more. Along with all this, TCL’s listed subsidiary Rallis India is focusing on manufacturing and growing its product portfolio to fill gaps to drive higher sales in the future.

article thumbnail

Best Defensive Stocks to keep an eye on in the event of a market crash

Trade Brains

These stocks offer protection during market volatility. They generally show lower price fluctuations compared to growth stocks, providing stability to a portfolio. During economic slowdowns, consumers continue to purchase necessities, allowing defensive stocks to maintain their performance relative to other market sectors.